Skip to content

Avalyn 药

US · AVLN #3161 按市值排名 上市于 2026
23.66 -0.98 -3.98%
实时 - 追踪5344个代码 - 心跳于403秒前 · 2026-10-16 19:30

最新新闻

  • Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • 评级变动
    Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53
    \u5e02\u573a\u8d44\u8baf · 2026/6/4
  • Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • Analysts Offer Insights on NA Companies: Avalyn Pharma Inc (AVLN) and EquipmentShare.com, Inc. (EQPT)
    TipRanks · 2026/8/13
  • 评级变动
    Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)
    TipRanks · 2026/6/4
  • Raymond James Initiates Avalyn Pharma(AVLN.US) With Buy Rating, Announces Target Price $60
    \u5e02\u573a\u8d44\u8baf · 2026/10/2
  • 评级变动
    Evercore Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $51
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • 评级变动
    Jefferies Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $52
    \u5e02\u573a\u8d44\u8baf · 2026/5/25
  • Jefferies Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $52
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • 评级变动
    Morgan Stanley Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $53
    \u5e02\u573a\u8d44\u8baf · 2026/5/26

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Avalyn 药 讨论区 0 条评论

发表评论